An iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, ...

Rusfertide acetate is under clinical development by Takeda Pharmaceutical and currently in Phase II for Hemochromatosis. According to GlobalData, Phase II drugs for Hemochromatosis does not have ...

Gaucher disease is a rare genetic disorder that causes the buildup of fatty substances in certain organs. Type 1 is the most common type of Gaucher disease, but it’s the least severe and has the ...

Therapeutic phlebotomy is a medical procedure in which blood is removed from the body to treat certain blood disorders like polycythemia vera or hemochromatosis. It is performed by a specialist known ...

About one quarter of older men who were homozygous for the HFE C282Y mutation had clinically evident disease. Most clinical cases of hereditary hemochromatosis occur in people who are homozygous ...

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Hemochromatosis - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering. This "Hemochromatosis- Pipeline Insight, 2024" report ...

A condition that causes excess iron accumulation in the body Hemochromatosis is a medical condition where people have excessive iron in the body. The most common cause is an inherited genetic change, ...